<!DOCTYPE html>
<html>
<head>
<style>
.rectangle1{
  width: 100%;
  height: 100px;
  background: #DADBDD;
  text-align: center;



}

body {
           text-align: center;
           /*background-image: url('img_girl.jpeg');*/
       }
.tableth{
  text-align:center;
  background-color:#FF6600;
  padding: 4px 30px 4px 8px;
  font-size:23px;
}
.tabletd{
  border: 1px solid #e3e3e3;
  padding:4px 8px;
  text-align:left;
  width:50%;
  font-size:15pt;


}

</style>
</head>
<body>
  <div class= "rectangle1">
    <h1 class="center" style="color:black;" style="font-size:25px;">
      Microbiology Department
     </h1>
     <h2 class="center" style="color:black;" style="font-size:22px;">
       Pain point & solution  analysis
      </h2>
  </div>
  <table>
    <tr>
      <th class="tableth" style="color:white;" >Pain Points</th>
      <th class="tableth" style="color:white;">Solutions</th>
    </tr>
    <tr>
      <td class="tabletd" style= "background-color: #FED8B1;font-size:15pt;">Current guidelines recommend brain imaging and cerebrospinal fluid analysis for diagnosing AD. However, a lumbar puncture can be painful, while brain imaging is expensive

</td>
<td class="tabletd" style= "background-color: #FED8B1; font-size:15pt;" rowspan="2" > <b>Blood test for Alzheimer’s diagnostics: </b>By developing a reliable and easily available immunoassays for blood-based t-tau or Aβ misfolding – both biomarker for AD – individuals at high risk of AD development can be identified and disease-modifying therapies could be administered early in the disease's progression – including patients with preexisting conditions such as Down syndrome.
</td>
</tr>
<tr>
      <td class="tabletd" style= "background-color: #FED8B1; font-size:15pt;">Patients with Down syndrome have an up to 80% risk of developing AD in their lifetime but due to the pre-existing intellectual disability.



</td>
</tr>
</table>

</body>
</html>
